Navigation Links
A new therapy without side effects could improve dramatically chemotherapy
Date:7/19/2011

Researchers of the University of Granada and Edimbourgh have developed a new therapy for cancer based on nanotechnology that might improve significantly chemotherapy, as it has not cause side effects.

This therapy is based on the encapsulation of a catalyst (palladium) into microspheres, to synthesize artificial materials or activate drugs within human cells, thus avoiding any toxicity. This system captures palladium within its microstructure. Palladium is a metal not found naturally in human cells that allows to catalyze chemical reactions within cells without altering its basic functions such as protein synthesis and metabolism. This technique allows to "create" anti-cancer drugs within cells, which could be used for the specific treatment of tumors and would improve dramatically current chemotherapy treatments.

The results of this research conducted in collaboration with the University of Kebangsaan (Malasia) were recently published in the prestigious journal Nature Chemistry.

Participation Of The University of Granada

Rosario Mara Snchez Martn the researcher that has developed this technology at the School of Chemistry of the University of Edimbourgh has recently joined the Department of Pharmaceutical and Organic Chemistry of the University of Granada.

Another of the scientists that forms this research group, Asier Unciti Broceta, did his undergraduate studies and doctorate at the Department of Pharmaceutical and Organic Chemistry at the University of Granada, and he currently continues his successful career in Edinburgh, where he was recently named Fellow of the Edinburgh Cancer Research UK Centre, and received the award of Young Life Scientist of the Year 2010 in Scotland. Additionally, he has founded a new company, Deliverics Ltd, based on one of his patents.

Researchers pointed that, given the wide range of therapeutic applications of nanotechnology, this research will be further developed by University of Granada professor Dr Sanchez Martin, who will continue her collaboration with the research group conducted by professor Mark Bradley of the University of Edimbourgh.


'/>"/>

Contact: Rosario Mara Snchez Martn
rmsanchez@ugr.es
0034-958-246-678
University of Granada
Source:Eurekalert

Related medicine news :

1. New therapy provides hope for millions of people suffering from bowel incontinence
2. Novel combined therapy extends life, diminishes pain in brain cancer patients
3. Virtual Reality May Help in Parkinsons Therapy
4. Mainz University Medical Center deploys new system for therapy of metastatic spinal tumors
5. Special Talk Therapy Seems to Help Dying Patients
6. New Combo Therapy May Prevent TB, Save Lives in People With HIV
7. Experiment aboard shuttle Atlantis will test novel therapy to build bone during space travel
8. High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy
9. EURTAC Phase III study: Erlotinib nearly doubles progression-free survival vs. chemotherapy
10. New therapy for childhood neuroblastoma proves feasible and safe
11. Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... Hackensack, N.J. has been honored by Enterprising Women magazine as one of its ... world’s top women business owners. Winners have demonstrated that they have fast-growth businesses, ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... Pioneer today launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates how this ... help farmers produce more and better food, with fewer resources. It highlights the ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. ... Pro . This new addition to the Mirroring360 product family combines device screen ... , Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... attempts to compare student test score performance for the 2015-16 school year across ... state’s voucher programs. Though it highlights important patterns in student test score performance, ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... way in unveiling cutting-edge birth defects research related to Zika virus during pregnancy, ... world’s premier society for this important science. , The Teratology Society ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: ... Burton & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel ... Wright , Chief Executive Officer of the Company is scheduled to ... Richard Bear and the Chairman of the Board, ... ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... Global Surgical Drainage Device Market: Overview ... remove excess liquid and air. The fluid to be ... lymph. Surgical drains are used in a wide variety ... cardiovascular surgery, neurosurgery, plastic surgery etc. Common use of ... of fluid e.g. blood or pus. Surgical drains are ...
Breaking Medicine Technology: